| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.
|
Endocrinology
|
2003
|
1.62
|
|
2
|
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor.
|
Cell Res
|
2006
|
1.51
|
|
3
|
The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis.
|
Exp Cell Res
|
2004
|
1.33
|
|
4
|
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
|
J Biol Chem
|
2003
|
1.31
|
|
5
|
Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
|
Cancer Res
|
2004
|
1.13
|
|
6
|
Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
|
J Biol Chem
|
2002
|
1.03
|
|
7
|
ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases.
|
Curr Pharm Des
|
2009
|
0.98
|
|
8
|
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
|
J Biol Chem
|
2003
|
0.98
|
|
9
|
Active roles of tumor stroma in breast cancer metastasis.
|
Int J Breast Cancer
|
2012
|
0.98
|
|
10
|
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
|
Biochem J
|
2004
|
0.98
|
|
11
|
Methodology and applications of disease biomarker identification in human serum.
|
Biomark Insights
|
2007
|
0.97
|
|
12
|
Enhancing QM/MM molecular dynamics sampling in explicit environments via an orthogonal-space-random-walk-based strategy.
|
J Phys Chem B
|
2011
|
0.95
|
|
13
|
Anion exchange fractionation of serum proteins versus albumin elimination.
|
Anal Biochem
|
2007
|
0.93
|
|
14
|
A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
|
Cancer Detect Prev
|
2005
|
0.92
|
|
15
|
ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
|
J Biol Chem
|
2011
|
0.92
|
|
16
|
Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites.
|
J Biol Chem
|
2002
|
0.91
|
|
17
|
Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
|
PLoS One
|
2013
|
0.90
|
|
18
|
Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents.
|
Med Res Rev
|
2011
|
0.89
|
|
19
|
Isoelectric point-based prefractionation of proteins from crude biological samples prior to two-dimensional gel electrophoresis.
|
J Proteome Res
|
2005
|
0.89
|
|
20
|
Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3.
|
Mol Hum Reprod
|
2002
|
0.88
|
|
21
|
Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.
|
Clin Exp Metastasis
|
2010
|
0.85
|
|
22
|
Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity.
|
J Biol Chem
|
2002
|
0.85
|
|
23
|
Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumors.
|
J Biomed Biotechnol
|
2011
|
0.84
|
|
24
|
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
|
Biochem J
|
2005
|
0.83
|
|
25
|
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.
|
Biochem J
|
2007
|
0.81
|
|
26
|
Protein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues.
|
J Cancer
|
2010
|
0.81
|
|
27
|
Expression of adamalysin 19/ADAM19 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy.
|
Mol Hum Reprod
|
2005
|
0.80
|
|
28
|
Prefractionation enhances loading capacity and identification of basic proteins from human breast cancer tissues.
|
Anal Biochem
|
2010
|
0.80
|
|
29
|
C-lysine conjugates: pH-controlled light-activated reagents for efficient double-stranded DNA cleavage with implications for cancer therapy.
|
J Am Chem Soc
|
2009
|
0.79
|
|
30
|
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
|
Ai Zheng
|
2009
|
0.78
|
|
31
|
Effects of detergents on catalytic activity of human endometase/matrilysin 2, a putative cancer biomarker.
|
Anal Biochem
|
2009
|
0.77
|
|
32
|
Characterization of the phosphoproteome in androgen-repressed human prostate cancer cells by Fourier transform ion cyclotron resonance mass spectrometry.
|
J Proteome Res
|
2011
|
0.77
|
|
33
|
Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry.
|
J Cancer
|
2012
|
0.77
|
|
34
|
Spatio-temporal expression of matrix metalloproteinase-26 in human placental trophoblasts and fetal red cells during normal placentation.
|
Biol Reprod
|
2004
|
0.77
|
|
35
|
Developmental and hormonal regulation of meltrin beta (ADAM19) expression in mouse testes during embryonic and postnatal life.
|
Life Sci
|
2006
|
0.77
|
|
36
|
The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells.
|
J Cancer
|
2013
|
0.76
|
|
37
|
Protein engineering and properties of human metalloproteinase and thrombospondin 1.
|
Biochem Biophys Res Commun
|
2002
|
0.76
|
|
38
|
Expression and implications of tissue inhibitor of metalloproteinases-4 in mouse embryo.
|
Mol Hum Reprod
|
2003
|
0.76
|
|
39
|
Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.
|
J Med Chem
|
2013
|
0.76
|
|
40
|
Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.
|
J Cancer
|
2011
|
0.75
|
|
41
|
Human coronary artery smooth muscle cell responses to bioactive polyelectrolyte multilayer interfaces.
|
Biotechnol Res Int
|
2010
|
0.75
|
|
42
|
Efficient soluble expression of secreted matrix metalloproteinase 26 in Brevibacillus choshinensis.
|
Protein Expr Purif
|
2013
|
0.75
|
|
43
|
Expression of tissue inhibitor of metalloproteinase-4 (TIMP-4) in endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy.
|
Life Sci
|
2005
|
0.75
|